Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of long-term dietary antioxidant supplementation on influenza virus infection.

Identifieur interne : 000A13 ( PubMed/Corpus ); précédent : 000A12; suivant : 000A14

Effect of long-term dietary antioxidant supplementation on influenza virus infection.

Auteurs : S N Han ; M. Meydani ; D. Wu ; B S Bender ; D E Smith ; J. Vi A ; G. Cao ; R L Prior ; S N Meydani

Source :

RBID : pubmed:11034223

English descriptors

Abstract

This study compared the effect of vitamin E on the course of influenza infection with that of other antioxidants. (In a previous study we showed that short-term vitamin E supplementation significantly decreased pulmonary viral titer in influenza-infected old mice). Eighteen-month-old C57BL/6NCrlBR mice were fed one of the following semisynthetic diets for 6 months: control, vitamin E supplemented, glutathione supplemented, vitamin E and glutathione supplemented, melatonin supplemented, or strawberry extract supplemented. After influenza virus challenge, mice fed vitamin E-supplemented diet had significantly lower pulmonary viral titers compared to those fed the control diet (10(2.6) vs 10(4.0), p < .05) and were able to maintain their body weight after infection (1.8+/-0.9 g weight loss/5 days postinfection in vitamin E group vs 6.8+/-1.4 g weight loss/5 days postinfection in control group, p < .05). Other antioxidants did not have a significant effect on viral titer or weight loss. There was a significant inverse correlation of weight loss with food intake (r = -.96, p < .01), indicating that the observed weight changes were mainly due to decreased food intake. Pulmonary interleukin (IL)-6, IL-1beta, and tumor necrosis factor (TNF)-alpha levels increased significantly postinfection. The vitamin E group had lower lung IL-6 and TNF-alpha levels following infection compared to the control group. In addition, there was a significant positive correlation between weight loss and lung IL-6 (r = .77, p < .01) and TNF-alpha (r = .68, p < .01) levels. Because IL-6 and TNF-alpha have been shown to contribute to the anorexic effect of infectious agents, the prevention of weight loss by vitamin E might be due to its reduced production of IL-6 and TNF-alpha following infection. Thus, among the antioxidants tested, only vitamin E was effective in reducing pulmonary viral titers and preventing an influenza-mediated decrease in food intake and weight loss. Other dietary antioxidant supplementations that reduced one or more measures of oxidative stress (4-hydroxynonenal, malondialdehyde, and hydrogen peroxide) did not have an effect on viral titer, which suggests that, in addition to its antioxidant activity, other mechanisms might be involved in vitamin E's beneficial effect on lowering viral titer and preventing weight loss.

DOI: 10.1093/gerona/55.10.b496
PubMed: 11034223

Links to Exploration step

pubmed:11034223

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of long-term dietary antioxidant supplementation on influenza virus infection.</title>
<author>
<name sortKey="Han, S N" sort="Han, S N" uniqKey="Han S" first="S N" last="Han">S N Han</name>
<affiliation>
<nlm:affiliation>Jean Mayer Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meydani, M" sort="Meydani, M" uniqKey="Meydani M" first="M" last="Meydani">M. Meydani</name>
</author>
<author>
<name sortKey="Wu, D" sort="Wu, D" uniqKey="Wu D" first="D" last="Wu">D. Wu</name>
</author>
<author>
<name sortKey="Bender, B S" sort="Bender, B S" uniqKey="Bender B" first="B S" last="Bender">B S Bender</name>
</author>
<author>
<name sortKey="Smith, D E" sort="Smith, D E" uniqKey="Smith D" first="D E" last="Smith">D E Smith</name>
</author>
<author>
<name sortKey="Vi A, J" sort="Vi A, J" uniqKey="Vi A J" first="J" last="Vi A">J. Vi A</name>
</author>
<author>
<name sortKey="Cao, G" sort="Cao, G" uniqKey="Cao G" first="G" last="Cao">G. Cao</name>
</author>
<author>
<name sortKey="Prior, R L" sort="Prior, R L" uniqKey="Prior R" first="R L" last="Prior">R L Prior</name>
</author>
<author>
<name sortKey="Meydani, S N" sort="Meydani, S N" uniqKey="Meydani S" first="S N" last="Meydani">S N Meydani</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11034223</idno>
<idno type="pmid">11034223</idno>
<idno type="doi">10.1093/gerona/55.10.b496</idno>
<idno type="wicri:Area/PubMed/Corpus">000A13</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A13</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effect of long-term dietary antioxidant supplementation on influenza virus infection.</title>
<author>
<name sortKey="Han, S N" sort="Han, S N" uniqKey="Han S" first="S N" last="Han">S N Han</name>
<affiliation>
<nlm:affiliation>Jean Mayer Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meydani, M" sort="Meydani, M" uniqKey="Meydani M" first="M" last="Meydani">M. Meydani</name>
</author>
<author>
<name sortKey="Wu, D" sort="Wu, D" uniqKey="Wu D" first="D" last="Wu">D. Wu</name>
</author>
<author>
<name sortKey="Bender, B S" sort="Bender, B S" uniqKey="Bender B" first="B S" last="Bender">B S Bender</name>
</author>
<author>
<name sortKey="Smith, D E" sort="Smith, D E" uniqKey="Smith D" first="D E" last="Smith">D E Smith</name>
</author>
<author>
<name sortKey="Vi A, J" sort="Vi A, J" uniqKey="Vi A J" first="J" last="Vi A">J. Vi A</name>
</author>
<author>
<name sortKey="Cao, G" sort="Cao, G" uniqKey="Cao G" first="G" last="Cao">G. Cao</name>
</author>
<author>
<name sortKey="Prior, R L" sort="Prior, R L" uniqKey="Prior R" first="R L" last="Prior">R L Prior</name>
</author>
<author>
<name sortKey="Meydani, S N" sort="Meydani, S N" uniqKey="Meydani S" first="S N" last="Meydani">S N Meydani</name>
</author>
</analytic>
<series>
<title level="j">The journals of gerontology. Series A, Biological sciences and medical sciences</title>
<idno type="ISSN">1079-5006</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aldehydes (metabolism)</term>
<term>Animals</term>
<term>Antioxidants (administration & dosage)</term>
<term>Diet</term>
<term>Interleukin-1 (metabolism)</term>
<term>Interleukin-6 (blood)</term>
<term>Interleukin-6 (metabolism)</term>
<term>Liver (metabolism)</term>
<term>Lung (virology)</term>
<term>Male</term>
<term>Malondialdehyde (metabolism)</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Orthomyxoviridae Infections (diet therapy)</term>
<term>Orthomyxoviridae Infections (virology)</term>
<term>Time Factors</term>
<term>Tumor Necrosis Factor-alpha (metabolism)</term>
<term>Viral Load</term>
<term>Weight Loss</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antioxidants</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Interleukin-6</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Aldehydes</term>
<term>Interleukin-1</term>
<term>Interleukin-6</term>
<term>Malondialdehyde</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="diet therapy" xml:lang="en">
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Liver</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Lung</term>
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Diet</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Time Factors</term>
<term>Viral Load</term>
<term>Weight Loss</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This study compared the effect of vitamin E on the course of influenza infection with that of other antioxidants. (In a previous study we showed that short-term vitamin E supplementation significantly decreased pulmonary viral titer in influenza-infected old mice). Eighteen-month-old C57BL/6NCrlBR mice were fed one of the following semisynthetic diets for 6 months: control, vitamin E supplemented, glutathione supplemented, vitamin E and glutathione supplemented, melatonin supplemented, or strawberry extract supplemented. After influenza virus challenge, mice fed vitamin E-supplemented diet had significantly lower pulmonary viral titers compared to those fed the control diet (10(2.6) vs 10(4.0), p < .05) and were able to maintain their body weight after infection (1.8+/-0.9 g weight loss/5 days postinfection in vitamin E group vs 6.8+/-1.4 g weight loss/5 days postinfection in control group, p < .05). Other antioxidants did not have a significant effect on viral titer or weight loss. There was a significant inverse correlation of weight loss with food intake (r = -.96, p < .01), indicating that the observed weight changes were mainly due to decreased food intake. Pulmonary interleukin (IL)-6, IL-1beta, and tumor necrosis factor (TNF)-alpha levels increased significantly postinfection. The vitamin E group had lower lung IL-6 and TNF-alpha levels following infection compared to the control group. In addition, there was a significant positive correlation between weight loss and lung IL-6 (r = .77, p < .01) and TNF-alpha (r = .68, p < .01) levels. Because IL-6 and TNF-alpha have been shown to contribute to the anorexic effect of infectious agents, the prevention of weight loss by vitamin E might be due to its reduced production of IL-6 and TNF-alpha following infection. Thus, among the antioxidants tested, only vitamin E was effective in reducing pulmonary viral titers and preventing an influenza-mediated decrease in food intake and weight loss. Other dietary antioxidant supplementations that reduced one or more measures of oxidative stress (4-hydroxynonenal, malondialdehyde, and hydrogen peroxide) did not have an effect on viral titer, which suggests that, in addition to its antioxidant activity, other mechanisms might be involved in vitamin E's beneficial effect on lowering viral titer and preventing weight loss.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11034223</PMID>
<DateCompleted>
<Year>2000</Year>
<Month>10</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>05</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1079-5006</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>55</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2000</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The journals of gerontology. Series A, Biological sciences and medical sciences</Title>
<ISOAbbreviation>J. Gerontol. A Biol. Sci. Med. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of long-term dietary antioxidant supplementation on influenza virus infection.</ArticleTitle>
<Pagination>
<MedlinePgn>B496-503</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This study compared the effect of vitamin E on the course of influenza infection with that of other antioxidants. (In a previous study we showed that short-term vitamin E supplementation significantly decreased pulmonary viral titer in influenza-infected old mice). Eighteen-month-old C57BL/6NCrlBR mice were fed one of the following semisynthetic diets for 6 months: control, vitamin E supplemented, glutathione supplemented, vitamin E and glutathione supplemented, melatonin supplemented, or strawberry extract supplemented. After influenza virus challenge, mice fed vitamin E-supplemented diet had significantly lower pulmonary viral titers compared to those fed the control diet (10(2.6) vs 10(4.0), p < .05) and were able to maintain their body weight after infection (1.8+/-0.9 g weight loss/5 days postinfection in vitamin E group vs 6.8+/-1.4 g weight loss/5 days postinfection in control group, p < .05). Other antioxidants did not have a significant effect on viral titer or weight loss. There was a significant inverse correlation of weight loss with food intake (r = -.96, p < .01), indicating that the observed weight changes were mainly due to decreased food intake. Pulmonary interleukin (IL)-6, IL-1beta, and tumor necrosis factor (TNF)-alpha levels increased significantly postinfection. The vitamin E group had lower lung IL-6 and TNF-alpha levels following infection compared to the control group. In addition, there was a significant positive correlation between weight loss and lung IL-6 (r = .77, p < .01) and TNF-alpha (r = .68, p < .01) levels. Because IL-6 and TNF-alpha have been shown to contribute to the anorexic effect of infectious agents, the prevention of weight loss by vitamin E might be due to its reduced production of IL-6 and TNF-alpha following infection. Thus, among the antioxidants tested, only vitamin E was effective in reducing pulmonary viral titers and preventing an influenza-mediated decrease in food intake and weight loss. Other dietary antioxidant supplementations that reduced one or more measures of oxidative stress (4-hydroxynonenal, malondialdehyde, and hydrogen peroxide) did not have an effect on viral titer, which suggests that, in addition to its antioxidant activity, other mechanisms might be involved in vitamin E's beneficial effect on lowering viral titer and preventing weight loss.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Jean Mayer Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meydani</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bender</LastName>
<ForeName>B S</ForeName>
<Initials>BS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>D E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Viña</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cao</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Prior</LastName>
<ForeName>R L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meydani</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Gerontol A Biol Sci Med Sci</MedlineTA>
<NlmUniqueID>9502837</NlmUniqueID>
<ISSNLinking>1079-5006</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000447">Aldehydes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007375">Interleukin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4Y8F71G49Q</RegistryNumber>
<NameOfSubstance UI="D008315">Malondialdehyde</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K1CVM13F96</RegistryNumber>
<NameOfSubstance UI="C027576">4-hydroxy-2-nonenal</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000447" MajorTopicYN="N">Aldehydes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007375" MajorTopicYN="N">Interleukin-1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008315" MajorTopicYN="N">Malondialdehyde</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000178" MajorTopicYN="Y">diet therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2000</Year>
<Month>10</Month>
<Day>18</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2001</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2000</Year>
<Month>10</Month>
<Day>18</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11034223</ArticleId>
<ArticleId IdType="doi">10.1093/gerona/55.10.b496</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A13 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A13 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:11034223
   |texte=   Effect of long-term dietary antioxidant supplementation on influenza virus infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:11034223" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021